| 发明名称 | Glycan-interacting compounds | ||
| 摘要 | The present invention provides glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them. | ||
| 申请公布号 | US9273142(B2) | 申请公布日期 | 2016.03.01 |
| 申请号 | US201314050773 | 申请日期 | 2013.10.10 |
| 申请人 | SIAMAB THERAPEUTICS, INC. | 发明人 | Ghaderi Darius;da Silva Ana Paula Galvao |
| 分类号 | C07K16/30;G01N33/574 | 主分类号 | C07K16/30 |
| 代理机构 | DT Ward, PC | 代理人 | DT Ward, PC ;Ward Donna T.;Sullivan Christopher P. |
| 主权项 | 1. An antibody comprising a heavy chain variable domain (VH) comprising the amino acid sequence of SEQ ID NO: 1 and a light chain variable domain (VL) comprising the amino acid sequence of SEQ ID NO: 2. | ||
| 地址 | Newton MA US | ||